Alzheimer’s disease, frontotemporal dementias, progressive supranuclear palsy, Corticobasal degeneration, Clinical Trial Study
< Back to Find a Trial

A Phase Ib, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Arm, Multiple-Dose Study to Assess The Safety, Tolerability, And Pharmacokinetics of Intravenous Crenezumab Administered in Patients With Mild to Moderate Alzheimer's Disease

ID
NCT02353598
Condition Studied
Alzheimer's Disease
Phase
Phase I
Status
Closed
Intervention
Crenezumab
Principal Investigator

Please go to ClinicalTrials.gov for more information.